Related Experiment Video
Updated: Aug 24, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
Published on: May 27, 2021
Ropinirole in Gilles de la Tourette syndrome
Marietta H Anca1, Nir Giladi, Amos D Korczyn
1Department of Neurology, Tel-Aviv Medical Center, and the Sieratzki Chair of Neurology, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Abstract:
The effects of treatment with ropinirole (0.25 to 0.5 mg bid) were examined using an open-label design for 8 weeks in 15 subjects with Gilles de la Tourette syndrome (GdlT). All patients completed the study, and most showed an improvement in their tics during treatment. Low-dose ropinirole may improve the motor features in GdlT, but further controlled studies are necessary.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Parkinson Disease ll: Pathophysiology

